Sling Eases Male SUI After Surgery
Retrourethral transobturator sling associated with a treatment success rate of 77.1% at one year.
Print Issue: October 01, 2009
First-Degree Relatives of CKD Patients Are at Higher CKD Risk
New findings make a case for renal disease screening of family members who have risk factors.
TAE Effective for Polycystic Kidney and Liver
Transcatheter polycystic embolization was well-tolerated, and no deaths occurred as a result.
Sodium Bicarbonate Does Not Decrease CIN Risk
A recent study shows that sodium bicarbonate is no better than saline in preventing contrast-induced nephropathy (CIN).
Taller Men Are At Higher Risk for Aggressive Prostate Cancer
The association is especially strong among men younger than 65 years, according to researchers.
Wider Use of Radiofrequency Ablation Possible
Radiofrequency ablation of small renal tumors in otherwise healthy patients preserves renal function.
Valrubicin Is Reintroduced for the Treatment of CIS
Endo Pharmaceuticals, of Chadds Ford, Pa., has reintroduced Valstar (valrubicin) for the treatment of carcinoma in situ (CIS) of the urinary bladder that is refractory to treatment with Bacillus-Calmette-Guérin (BCG).
Patent is Filed for Device To Ease Catheter Insertion
Urovalve, of Newark, N.J., has filed a patent for a device that facilitates insertion of catheters, such as Foley catheters, the company said.
Anti-CMV Drug Cleared for Pediatric Transplant Patients
The FDA has approved Valcyte (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant recipients (aged four months to 16 years) who are at high risk of developing the disease.
Orally Dissolving Tablets for Diabetic Gastroparesis Cleared
Salix Pharmaceuticals has receiving marketing clearance for Metozolv (metoclopramide HCl) ODT (orally dissolving tablets) 5 mg and 10 mg orally disintegrating tablets for the relief of diabetic gastroparesis and symptomatic documented gastroesophageal reflux (GERD).
